These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32851945)

  • 1. A Conceptual Framework for Research on Cognitive Impairment with no Dementia in Memory Clinic.
    Huang L; Chen K; Liu Z; Guo Q
    Curr Alzheimer Res; 2020; 17(6):517-525. PubMed ID: 32851945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.
    Wong CG; Thomas KR; Edmonds EC; Weigand AJ; Bangen KJ; Eppig JS; Jak AJ; Devine SA; Delano-Wood L; Libon DJ; Edland SD; Au R; Bondi MW
    Dement Geriatr Cogn Disord; 2018; 46(5-6):253-265. PubMed ID: 30391953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study.
    Jak AJ; Preis SR; Beiser AS; Seshadri S; Wolf PA; Bondi MW; Au R
    J Int Neuropsychol Soc; 2016 Oct; 22(9):937-943. PubMed ID: 27029348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on the validations of three cognitive screening tests in identifying subtle cognitive decline.
    Pan FF; Huang L; Chen KL; Zhao QH; Guo QH
    BMC Neurol; 2020 Mar; 20(1):78. PubMed ID: 32138678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
    Bondi MW; Edmonds EC; Jak AJ; Clark LR; Delano-Wood L; McDonald CR; Nation DA; Libon DJ; Au R; Galasko D; Salmon DP
    J Alzheimers Dis; 2014; 42(1):275-89. PubMed ID: 24844687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Neuropsychological Process Scores to Identify Subtle Cognitive Decline and Predict Progression to Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Eppig J; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2018; 64(1):195-204. PubMed ID: 29865077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.
    Wolfsgruber S; Polcher A; Koppara A; Kleineidam L; Frölich L; Peters O; Hüll M; Rüther E; Wiltfang J; Maier W; Kornhuber J; Lewczuk P; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 58(3):939-950. PubMed ID: 28527210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The criteria used to rule out mild cognitive impairment impact dementia incidence rates in subjective cognitive decline.
    Whitfield T; Chouliaras L; Morrell R; Rubio D; Radford D; Marchant NL; Walker Z
    Alzheimers Res Ther; 2024 Jun; 16(1):142. PubMed ID: 38943160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing Mild Cognitive Impairment Among Racially Diverse Older Adults: Comparison of Consensus, Actuarial, and Statistical Methods.
    Devlin KN; Brennan L; Saad L; Giovannetti T; Hamilton RH; Wolk DA; Xie SX; Mechanic-Hamilton D
    J Alzheimers Dis; 2022; 85(2):627-644. PubMed ID: 34864658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion.
    Scharre DW; Chang SI; Nagaraja HN; Wheeler NC; Kataki M
    Alzheimers Res Ther; 2021 Dec; 13(1):192. PubMed ID: 34872596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG; Holden S; Bernard B; Ouyang B; Goetz CG; Stebbins GT
    Mov Disord; 2013 Dec; 28(14):1972-9. PubMed ID: 24123267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Face-Name Associative Recognition Deficits in Subjective Cognitive Decline and Mild Cognitive Impairment.
    Polcher A; Frommann I; Koppara A; Wolfsgruber S; Jessen F; Wagner M
    J Alzheimers Dis; 2017; 56(3):1185-1196. PubMed ID: 28106560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Amnestic Severity Predicts Progression From Amnestic Mild Cognitive Impairment to Alzheimer Disease Dementia at 3 Years.
    Bradfield NI; Ellis KA; Savage G; Maruff P; Burnham S; Darby D; Lautenschlager NT; Martins RN; Masters CL; Rainey-Smith SR; Robertson J; Rowe C; Woodward M; Ames D
    Alzheimer Dis Assoc Disord; 2018; 32(3):190-196. PubMed ID: 29561277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mild behavioral impairment in mild cognitive impairment and subjective cognitive decline, and its association with caregiver burden.
    Sheikh F; Ismail Z; Mortby ME; Barber P; Cieslak A; Fischer K; Granger R; Hogan DB; Mackie A; Maxwell CJ; Menon B; Mueller P; Patry D; Pearson D; Quickfall J; Sajobi T; Tse E; Wang M; Smith EE;
    Int Psychogeriatr; 2018 Feb; 30(2):233-244. PubMed ID: 28879833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Homocysteine - A predictor for five year-mortality in patients with subjective cognitive decline, mild cognitive impairment and Alzheimer's dementia.
    Futschek IE; Schernhammer E; Haslacher H; Stögmann E; Lehrner J
    Exp Gerontol; 2023 Feb; 172():112045. PubMed ID: 36509298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.
    Kirsebom BE; Espenes R; Waterloo K; Hessen E; Johnsen SH; Bråthen G; Aarsland D; Fladby T
    J Alzheimers Dis; 2017; 60(4):1621-1631. PubMed ID: 28984581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological predictors of cognitive deterioration in non-demented individuals.
    Kim HG; Jung HS; Koo BH; Cheon EJ
    Cogn Neuropsychiatry; 2020 Mar; 25(2):99-112. PubMed ID: 31791187
    [No Abstract]   [Full Text] [Related]  

  • 19. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort.
    Narasimhalu K; Ang S; De Silva DA; Wong MC; Chang HM; Chia KS; Auchus AP; Chen C
    Neurology; 2009 Dec; 73(22):1866-72. PubMed ID: 19949033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study.
    Di Carlo A; Baldereschi M; Lamassa M; Bovis F; Inzitari M; Solfrizzi V; Panza F; Galluzzo L; Scafato E; Inzitari D;
    J Alzheimers Dis; 2016 May; 53(2):505-15. PubMed ID: 27163817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.